Juma Rashid - Concepedia

Author

Juma Rashid

Kenya Medical Research Institute

Also Known As

J R Rashid, J. R. RASHID, J. R. Rashid, J. RASHID, J.R. Rashid, Juma Rashid, Rashid Juma

Publications

924

Citations

H-Index

Concepts

All Affiliations

Kenya Medical Research Institute Drugs for Neglected Diseases Initiative University of Khartoum Addis Ababa University Makerere University

About

Juma Rashid is an author at Kenya Medical Research Institute specializing in medicine, parasitology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	197
2	Public Health	1	1	26
3	Biology	1	1	67
4	Epidemiology	1	1	26
5	Global Health	1	1	26

Juma Rashid

Publications

902

Citations

H-Index

Page 1

	Year	Citations
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial Ahmed Musa, Eltahir Awad Gasim Khalil, Asrat Hailu, PLoS neglected tropical diseases	2012	168
Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial Asrat Hailu, Ahmed Musa, Monique Wasunna, PLoS neglected tropical diseases	2010	144
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial Monique Wasunna, Simon Njenga, Manica Balasegaram, PLoS neglected tropical diseases	2016	103
Quercetin, an <i>in vitro</i> inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice Juma Rashid, Craig A. McKinstry, A. G. Renwick, British Journal of Clinical Pharmacology	1993	98
Visceral leishmaniasis unresponsive to antimonial drugs III. Successful treatment using a combination of sodium stibogluconate plus allopurinol C.N. Chunge, G. Gacmra, R. Muigai, Transactions of the Royal Society of Tropical Medicine and Hygiene Sodium StibogluconateDivided DosesSuccessful TreatmentAntiparasitic AgentMedicine	1985	91
Phase 2 Efficacy Trial of an Oral 8-Aminoquinoline (WR6026) for Treatment of Visceral Leishmaniasis James A. Sherwood, G. Gachihi, R. Muigai, Clinical Infectious Diseases	1994	91
Impact of the crayfish Procambarus clarkii on Schistosoma haematobium transmission in Kenya. Gerald M. Mkoji, Bruce V. Hofkin, Armand M. Kuris, American Journal of Tropical Medicine and Hygiene BiologyParasitic DiseaseMolluscan Intermediate HostsMalariaParasite Control	1999	67
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme Robert Kimutai, Ahmed Musa, Simon Njoroge, Clinical Drug Investigation	2017	61
The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis Monique Wasunna, Ahmed Musa, Asrat Hailu, Transactions of the Royal Society of Tropical Medicine and Hygiene African TrypanosomiasisTranslational MedicineParasitic ProtozoaTreatment And PreventionAlternative Medicine	2016	26
A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers Roma Chilengi, Juma Rashid, Ahmed M Abdallah, Malaria Journal	2011	21

Page 1